These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1149948)

  • 1. Serum IRI in insulin-treated diabetics during a 24-hour period.
    Rasmussen SM; Heding LG; Parbst E; Volund A
    Diabetologia; 1975 Apr; 11(2):151-8. PubMed ID: 1149948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between circulating free and bound insulin, insulin antibodies, insulin dosage and diabetic control in insulin treated diabetics.
    Asplin CM; Hartog M; Goldie DJ
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):330-8. PubMed ID: 580135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for the immunoassay of insulin in the presence of insulin therapy-induced antibody.
    Davidson P; Deal RB
    J Lab Clin Med; 1976 Jun; 87(6):1050-6. PubMed ID: 778312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA- and insulin-containing (C3-fixing) circulating immune complexes in diabetes mellitus.
    Triolo G; Giardina E; Rinaldi A; Bompiani GD
    Clin Immunol Immunopathol; 1984 Feb; 30(2):169-77. PubMed ID: 6692599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No relationship between insulin antibodies and hypoglycemia in insulin-treated diabetic patients.
    Ionescu-Tîrgovişte C; Mirodon Z; Paterache E; Cheţa D; Mincu I
    Rom J Intern Med; 1991; 29(3-4):189-98. PubMed ID: 1784948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-lowering effect of insulin by different routes in obese and lean nonketotic diabetic patients.
    Shahshahani MN; Kitabchi
    J Clin Endocrinol Metab; 1978 Jul; 47(1):34-40. PubMed ID: 400713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-insulin antibodies are a cause of hypoglycemia following pancreas transplantation.
    Tran MP; Larsen JL; Duckworth WC; Ruby EI; Miller SA; Frisbie K; Taylor RJ; Stratta RJ
    Diabetes Care; 1994 Sep; 17(9):988-93. PubMed ID: 7988320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of enteroinsular hormones at birth to macrosomia and neonatal hypoglycemia in infants of diabetic mothers.
    Knip M; Lautala P; Leppäluoto J; Akerblom HK; Kouvalainen K
    J Pediatr; 1983 Oct; 103(4):603-11. PubMed ID: 6352886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin secretion after oral calcium load.
    Fujita T; Sakagami Y; Tomita T; Okamoto Y; Oku H
    Endocrinol Jpn; 1978 Dec; 25(6):645-8. PubMed ID: 751809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases.
    Kajinuma H; Kanazawa Y; Sando H; Hayashi M; Kawazu S; Kosaka K
    Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin, insulin antibodies and insulin requirement in the first period of insulin treatment in non-insulin resistant diabetics.
    Lev-Ran A; Ratt L; Gersht N
    Acta Diabetol Lat; 1975; 12(1):66-71. PubMed ID: 1229807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological hypoglycemia associated with insulin antibodies induced by exogenous insulin in 11 Chinese patients with diabetes.
    Quan H; Tan H; Li Q; Li J; Li S
    J Diabetes Res; 2015; 2015():746271. PubMed ID: 25961056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic and hormonal profile of the offsprings of conjugal diabetics.
    Mahtab H; Ara S; Banik NG; Chowdhury NA; Azad Khan AK
    Bangladesh Med Res Counc Bull; 1982 Jun; 8(1):7-14. PubMed ID: 6756373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
    Ubukata E
    Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human C-peptide in normal and diabetic subjects.
    Heding LG; Rasmussen SM
    Diabetologia; 1975 Jun; 11(3):201-6. PubMed ID: 1149953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin antibodies and management of diabetes after total pancreatectomy.
    Ishikawa O; Ohhigashi H; Sasakuma F; Imaoka S; Hasegawa K; Okishio T; Sasaki Y; Koyama H; Iwanaga T
    Surgery; 1989 Jan; 105(1):57-64. PubMed ID: 2643197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between diabetics receiving a high or low daily insulin dosage.
    Asplin CM; Hartog M; Goldie DJ; Alberti KG; Smythe P; Binder C; Fabero OK
    Horm Metab Res; 1978 Sep; 10(5):365-9. PubMed ID: 568594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum antibody-bound insulin as a measure of insulin antibodies in diabetic children.
    Koskinen P; Kaihola HL; Mäkelä AL; Irjala K; Knip M; Akerblom HK
    Diabetes Res; 1987 Sep; 6(1):15-9. PubMed ID: 3319351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
    Crockett SE; Mazzaferri EL; Cataland S
    Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.